113 related articles for article (PubMed ID: 37582322)
1. Сell clusters isolation in glioblastomas and their functional and molecular characterization using new morphometric approaches.
Nikitin PV; Musina GR; Fayzullin AL; Bakulina AA; Nikolaev VN; Mikhailov VP; Werkenbark L; Kjelin M; Usachev DY; Timashev PS
Comput Biol Med; 2023 Sep; 164():107322. PubMed ID: 37582322
[TBL] [Abstract][Full Text] [Related]
2. [Heterogeneity of tumor cells in glioblastomas].
Nikitin PV; Ryzhova MV; Zubova IV; Panina TN; Shugay SV
Arkh Patol; 2019; 81(3):27-36. PubMed ID: 31317928
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal and Proneural Subtypes of Glioblastoma Disclose Branching Based on GSC Associated Signature.
Steponaitis G; Tamasauskas A
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066996
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of ex-vivo CD133+ GBM cells revealed a common invasive and angiogenic profile but different proliferative signatures among high grade gliomas.
Garcia JL; Perez-Caro M; Gomez-Moreta JA; Gonzalez F; Ortiz J; Blanco O; Sancho M; Hernandez-Rivas JM; Gonzalez-Sarmiento R; Sanchez-Martin M
BMC Cancer; 2010 Aug; 10():454. PubMed ID: 20735813
[TBL] [Abstract][Full Text] [Related]
5. Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation.
Kessler T; Sahm F; Sadik A; Stichel D; Hertenstein A; Reifenberger G; Zacher A; Sabel M; Tabatabai G; Steinbach J; Sure U; Krex D; Grosu AL; Bewerunge-Hudler M; Jones D; Pfister SM; Weller M; Opitz C; Bendszus M; von Deimling A; Platten M; Wick W
Neuro Oncol; 2018 Feb; 20(3):367-379. PubMed ID: 29016808
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor.
Lee HK; Bier A; Cazacu S; Finniss S; Xiang C; Twito H; Poisson LM; Mikkelsen T; Slavin S; Jacoby E; Yalon M; Toren A; Rempel SA; Brodie C
PLoS One; 2013; 8(2):e54652. PubMed ID: 23390502
[TBL] [Abstract][Full Text] [Related]
7. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
8. Quiescent stem cell marker genes in glioma gene networks are sufficient to distinguish between normal and glioblastoma (GBM) samples.
Mukherjee S
Sci Rep; 2020 Jul; 10(1):10937. PubMed ID: 32616845
[TBL] [Abstract][Full Text] [Related]
9. A map of the spatial distribution and tumour-associated macrophage states in glioblastoma and grade 4 IDH-mutant astrocytoma.
Yin W; Ping YF; Li F; Lv SQ; Zhang XN; Li XG; Guo Y; Liu Q; Li TR; Yang LQ; Yang KD; Liu YQ; Luo CH; Luo T; Wang WY; Mao M; Luo M; He ZC; Cao MF; Chen C; Miao JY; Zeng H; Wang C; Zhou L; Yang Y; Yang X; Wang QH; Feng H; Shi Y; Bian XW
J Pathol; 2022 Oct; 258(2):121-135. PubMed ID: 35723032
[TBL] [Abstract][Full Text] [Related]
10. Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma.
Tafani M; Di Vito M; Frati A; Pellegrini L; De Santis E; Sette G; Eramo A; Sale P; Mari E; Santoro A; Raco A; Salvati M; De Maria R; Russo MA
J Neuroinflammation; 2011 Apr; 8():32. PubMed ID: 21489226
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
[TBL] [Abstract][Full Text] [Related]
12. Molecular classification of glioblastoma based on immunohistochemical expression of EGFR, PDGFRA, NF1, IDH1, p53 and PTEN proteins.
Jankowska S; Lewandowska M; Masztalewicz M; Sagan L; Nowacki P; Urasińska E
Pol J Pathol; 2021; 72(1):1-10. PubMed ID: 34060283
[TBL] [Abstract][Full Text] [Related]
13. Automated Grading of Gliomas using Deep Learning in Digital Pathology Images: A modular approach with ensemble of convolutional neural networks.
Ertosun MG; Rubin DL
AMIA Annu Symp Proc; 2015; 2015():1899-908. PubMed ID: 26958289
[TBL] [Abstract][Full Text] [Related]
14. Unsupervised deep learning reveals prognostically relevant subtypes of glioblastoma.
Young JD; Cai C; Lu X
BMC Bioinformatics; 2017 Oct; 18(Suppl 11):381. PubMed ID: 28984190
[TBL] [Abstract][Full Text] [Related]
15. A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas.
Higa N; Akahane T; Yokoyama S; Yonezawa H; Uchida H; Takajo T; Kirishima M; Hamada T; Matsuo K; Fujio S; Hanada T; Hosoyama H; Yonenaga M; Sakamoto A; Hiraki T; Tanimoto A; Yoshimoto K
Cancer Sci; 2020 Oct; 111(10):3902-3911. PubMed ID: 32748499
[TBL] [Abstract][Full Text] [Related]
16. Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria.
Günther HS; Schmidt NO; Phillips HS; Kemming D; Kharbanda S; Soriano R; Modrusan Z; Meissner H; Westphal M; Lamszus K
Oncogene; 2008 May; 27(20):2897-909. PubMed ID: 18037961
[TBL] [Abstract][Full Text] [Related]
17. Tumor cell network integration in glioma represents a stemness feature.
Xie R; Kessler T; Grosch J; Hai L; Venkataramani V; Huang L; Hoffmann DC; Solecki G; Ratliff M; Schlesner M; Wick W; Winkler F
Neuro Oncol; 2021 May; 23(5):757-769. PubMed ID: 33320195
[TBL] [Abstract][Full Text] [Related]
18. The landscape of the mesenchymal signature in brain tumours.
Behnan J; Finocchiaro G; Hanna G
Brain; 2019 Apr; 142(4):847-866. PubMed ID: 30946477
[TBL] [Abstract][Full Text] [Related]
19. A glycolysis-based ten-gene signature correlates with the clinical outcome, molecular subtype and IDH1 mutation in glioblastoma.
Chen C; Shi Y; Li Y; He ZC; Zhou K; Zhang XN; Yang KD; Wu JR; Kung HF; Ping YF; Bian XW
J Genet Genomics; 2017 Nov; 44(11):519-530. PubMed ID: 29169920
[TBL] [Abstract][Full Text] [Related]
20. Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma.
Murat A; Migliavacca E; Gorlia T; Lambiv WL; Shay T; Hamou MF; de Tribolet N; Regli L; Wick W; Kouwenhoven MC; Hainfellner JA; Heppner FL; Dietrich PY; Zimmer Y; Cairncross JG; Janzer RC; Domany E; Delorenzi M; Stupp R; Hegi ME
J Clin Oncol; 2008 Jun; 26(18):3015-24. PubMed ID: 18565887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
